March 20, 2024, 11:12 a.m. | SC Staff

SC Magazine feed for Risk Management www.scmagazine.com

U.S. endocrine-focused pharmaceutical development and commercialization firm Crinetics Pharmaceuticals has confirmed an ongoing investigation into a cybersecurity incident claimed by the LockBit ransomware operation.

cyberattack cybersecurity cybersecurity incident development incident investigation lockbit lockbit ransomware pharmaceutical pharmaceuticals ransomware under

CyberSOC Technical Lead

@ Integrity360 | Sandyford, Dublin, Ireland

Cyber Security Strategy Consultant

@ Capco | New York City

Cyber Security Senior Consultant

@ Capco | Chicago, IL

Sr. Product Manager

@ MixMode | Remote, US

Corporate Intern - Information Security (Year Round)

@ Associated Bank | US WI Remote

Senior Offensive Security Engineer

@ CoStar Group | US-DC Washington, DC